Immunosuppression: Clinical Trials

2 trials for Immunosuppression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Completed 2

Follow Immunosuppression: new trials by email Literature Review of Immunosuppression trials Research Report on Immunosuppression

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma
Nivolumab - Kaposi Sarcoma, HIV/AIDS
Early Phase 1CompletedUniversity of California, San Francisco122018-05-072024-06-25
MPA PK Monitoring Strategy With MMF/FK Based Immunosuppression
Mycophenolate Mofetil - Transplantation, Renal, Immunosuppression
Early Phase 1CompletedUniversity of Florida222005-08-012012-06-20

Narrower conditions

Acquired Immunodeficiency Syndrome (1)  ·  Sarcoma, Kaposi (1)

Broader conditions

Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  DNA Virus Infections (1)  ·  Genital Diseases (1)  ·  HIV Infections (1)  ·  Herpesviridae Infections (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Neoplasms, Vascular Tissue (1)  ·  RNA Virus Infections (1)

Interventions

Mycophenolic Acid (1)  ·  Nivolumab (1)

Sponsors

University of California, San Francisco (1)  ·  University of Florida (1)

Countries

United States (2)

Top investigators

Chia-ching Wang, MD (1)  ·  Herwig-Ulf Meier-Kriesche, MD (1)

NIH funding

P30CA082103 (1)